$IDAI
T Stamp Inc

2023 Q2 Form 10-Q Financial Statement

#000141057823001167 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $460.8K $458.6K
YoY Change -34.94% -83.74%
Cost Of Revenue $203.9K $217.0K
YoY Change -41.43% -68.74%
Gross Profit $256.9K $241.7K
YoY Change -28.67% -88.64%
Gross Profit Margin 55.74% 52.69%
Selling, General & Admin $1.878M $1.970M
YoY Change -25.87% -36.87%
% of Gross Profit 730.96% 815.11%
Research & Development $574.4K $632.4K
YoY Change -0.02% 28.09%
% of Gross Profit 223.62% 261.67%
Depreciation & Amortization $187.3K $219.2K
YoY Change 345.88% 42.39%
% of Gross Profit 72.9% 90.69%
Operating Expenses $2.639M $3.038M
YoY Change -27.62% -31.91%
Operating Profit -$2.382M -$2.580M
YoY Change -18.91% 57.19%
Interest Expense -$9.790K -$11.57K
YoY Change -128.69% -131.59%
% of Operating Profit
Other Income/Expense, Net $221.8K $32.30K
YoY Change 1318.89% -163.41%
Pretax Income -$2.170M -$2.547M
YoY Change -25.73% 50.55%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.170M -$2.547M
YoY Change -25.73% 50.55%
Net Earnings / Revenue -471.0% -555.44%
Basic Earnings Per Share -$0.32 -$0.50
Diluted Earnings Per Share -$0.32 -$0.50
COMMON SHARES
Basic Shares Outstanding 6.697M 4.854M
Diluted Shares Outstanding 6.757M shares 5.045M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.035M $773.1K
YoY Change 78.08% -86.75%
Cash & Equivalents $5.035M $773.1K
Short-Term Investments
Other Short-Term Assets $312.7K $297.9K
YoY Change -43.06% -71.91%
Inventory
Prepaid Expenses $236.5K
Receivables $486.7K $533.5K
Other Receivables $222.7K $195.1K
Total Short-Term Assets $6.057M $1.800M
YoY Change 40.78% -77.76%
LONG-TERM ASSETS
Property, Plant & Equipment $277.6K $82.11K
YoY Change -24.7% -26.42%
Goodwill $1.249M
YoY Change 0.0%
Intangibles $238.8K
YoY Change 16.7%
Long-Term Investments
YoY Change
Other Assets $11.13K $2.066K
YoY Change -92.61% -98.63%
Total Long-Term Assets $3.232M $3.361M
YoY Change -2.52% 13.47%
TOTAL ASSETS
Total Short-Term Assets $6.057M $1.800M
Total Long-Term Assets $3.232M $3.361M
Total Assets $9.289M $5.161M
YoY Change 21.94% -53.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $774.0K $1.365M
YoY Change 94.53% 108.79%
Accrued Expenses $801.5K $1.191M
YoY Change 70.96% -9.66%
Deferred Revenue $2.747M
YoY Change 754.45%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $162.1K
YoY Change 36.34%
Total Short-Term Liabilities $4.590M $5.893M
YoY Change 236.41% 139.05%
LONG-TERM LIABILITIES
Long-Term Debt $921.9K $907.6K
YoY Change 7.46% 8.29%
Other Long-Term Liabilities $297.9K $319.7K
YoY Change -33.18% -4.33%
Total Long-Term Liabilities $1.220M $907.6K
YoY Change 42.18% 8.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.590M $5.893M
Total Long-Term Liabilities $1.220M $907.6K
Total Liabilities $5.972M $7.120M
YoY Change 123.8% 95.75%
SHAREHOLDERS EQUITY
Retained Earnings -$41.85M
YoY Change 44.81%
Common Stock $51.22K
YoY Change -77.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.318M -$2.120M
YoY Change
Total Liabilities & Shareholders Equity $9.289M $5.161M
YoY Change 21.94% -53.31%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.170M -$2.547M
YoY Change -25.73% 50.55%
Depreciation, Depletion And Amortization $187.3K $219.2K
YoY Change 345.88% 42.39%
Cash From Operating Activities -$3.427M -$155.0K
YoY Change 26.1% -86.4%
INVESTING ACTIVITIES
Capital Expenditures $203.4K $191.2K
YoY Change -169.45% 1801.08%
Acquisitions
YoY Change
Other Investing Activities $377.4K
YoY Change 2724.55%
Cash From Investing Activities $174.0K -$191.2K
YoY Change -162.25% -21.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.518M -103.1K
YoY Change -78091.8% -102.79%
NET CHANGE
Cash From Operating Activities -3.427M -155.0K
Cash From Investing Activities 174.0K -191.2K
Cash From Financing Activities 7.518M -103.1K
Net Change In Cash 4.266M -481.4K
YoY Change -241.87% -120.39%
FREE CASH FLOW
Cash From Operating Activities -$3.427M -$155.0K
Capital Expenditures $203.4K $191.2K
Free Cash Flow -$3.630M -$346.2K
YoY Change 49.72% -69.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4549686
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5044775
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4549686
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001718939
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.20
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y6M
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41252
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
T Stamp Inc
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3017 Bolling Way NE, Floors 1 and 2
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30305
CY2023Q1 dei City Area Code
CityAreaCode
404
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
806-9906
CY2023Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
IDAI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6696677
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
773114
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254494
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
89749
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
109475
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
533464
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1008375
CY2023Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
30750
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
31446
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
462244
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
580086
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1799572
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2874401
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1445663
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1418672
CY2023Q1 us-gaap Goodwill
Goodwill
1248664
CY2022Q4 us-gaap Goodwill
Goodwill
1248664
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
238810
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
251686
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82109
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300664
CY2023Q1 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
177910
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
166024
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
315765
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2066
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2066
CY2023Q1 us-gaap Assets
Assets
5160818
CY2022Q4 us-gaap Assets
Assets
6411918
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1365049
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
945162
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
311138
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
273176
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1191118
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1099824
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2746969
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1811680
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
21076
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21076
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79269
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177795
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
118860
CY2023Q1 idai Financial Liabilities Held For Sale Current
FinancialLiabilitiesHeldForSaleCurrent
177905
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5892524
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4447573
CY2023Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
262909
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
261569
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
9904
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
16458
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
907616
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
886465
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56739
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102407
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
88760
CY2023Q1 us-gaap Liabilities
Liabilities
7119788
CY2022Q4 us-gaap Liabilities
Liabilities
5786774
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5121607
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4910815
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5121607
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4854302
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
51216
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
48543
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
56513
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39479741
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39496183
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
18547
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
195810
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
237252
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41847176
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39299726
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2120409
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
463705
CY2023Q1 us-gaap Minority Interest
MinorityInterest
161439
CY2022Q4 us-gaap Minority Interest
MinorityInterest
161439
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1958970
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625144
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5160818
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6411918
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458633
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2821044
CY2023Q1 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
216958
CY2022Q1 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
693978
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
632369
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493686
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1969875
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3120572
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
219181
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
153928
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3038383
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4462164
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2579750
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1641120
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10231
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3958
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1340
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-40588
CY2023Q1 idai Others Non Operating Income
OthersNonOperatingIncome
44614
CY2022Q1 idai Others Non Operating Income
OthersNonOperatingIncome
6941
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
743
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
94513
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32300
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50942
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2547450
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1692062
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2547450
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1692062
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4549686
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2547450
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1692062
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41442
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
62650
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-41442
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
62650
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2588892
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1629412
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2588892
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1629412
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022Q1 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
3383762
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53314
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
203438
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
55838
CY2022Q1 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
27930
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
287786
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
62650
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7416372
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625144
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2023Q1 idai Issuance Of Treasury Stock To Employees In Relation To Vested Restricted Stock Units Net Of Taxes
IssuanceOfTreasuryStockToEmployeesInRelationToVestedRestrictedStockUnitsNetOfTaxes
-75343
CY2023Q1 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
18547
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59574
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41442
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1958970
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219181
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153928
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
59574
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
287786
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1340
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-40588
CY2023Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
18547
CY2022Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
27930
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
9904
CY2023Q1 idai Non Cash Lease Expense
NonCashLeaseExpense
66759
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-897
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-474911
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-244927
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-696
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-13394
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-123177
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
224939
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27539
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
419887
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
349640
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
91294
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
254738
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
37962
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-81552
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
935289
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-181943
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-66546
CY2022Q1 idai Increase Decrease In Customer Deposits Liability
IncreaseDecreaseInCustomerDepositsLiability
-280108
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-154578
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1141310
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10059
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
167668
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
206523
CY2023Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
23563
CY2022Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
28173
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191231
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-244755
CY2022Q1 idai Proceeds From Exercise Of Warrants To Common Stock
ProceedsFromExerciseOfWarrantsToCommonStock
3383762
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
53314
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
75343
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203438
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
55838
CY2023Q1 idai Principal Payment On Derivatives
PrincipalPaymentOnDerivatives
29715
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-103058
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3696352
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-32513
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50169
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-481380
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2360456
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1254494
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3475695
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
773114
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5836151
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
570
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
8
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
82982
CY2023Q1 idai Non Cash Activity Of Operating Lease Liabilities Related To Terminated Leases
NonCashActivityOfOperatingLeaseLiabilitiesRelatedToTerminatedLeases
77648
CY2023Q1 idai Non Cash Activity Of Prepaid Rent Expense Reclassified Upon Termination Of Leases
NonCashActivityOfPrepaidRentExpenseReclassifiedUponTerminationOfLeases
5335
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2550000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-155000
CY2023Q1 idai Working Capital In Business
WorkingCapitalInBusiness
4090000.00
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41850000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y5M1D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5365737
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7443
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.20
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">—</span><i style="font-style:italic;"> </i>The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates their estimates that include, but are not limited to, percentage of completion related to revenue contracts that are not fully complete at the end of a fiscal quarter, capitalization and estimated useful life of internal-use software, the allowance for doubtful accounts, the fair value of financial assets and liabilities, the recoverability of goodwill, stock-based compensation including the determination of the fair value of our common stock, impairment of long-lived assets, the valuation of deferred tax assets and uncertain tax positions, and warrant liabilities. We base our estimates on assumptions, both historical and forward-looking trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Major Customers and Concentration of Risks </span><span style="font-style:italic;font-weight:bold;">—</span> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. We maintain our cash and cash equivalents with high-quality financial institutions, mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250 thousand for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of March 31, 2023 and December 31, 2022, the Company had $284 thousand and $71 thousand in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">Three customers represented 93.21% or 62.04%, 15.94%, and 15.23% of the balance of total accounts receivable as of March 31, 2023 and three customers represented 95.37% or 36.90%, 32.69%, and 25.78% of the balance of total accounts receivable as of December 31, 2022. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of accounts receivable balances. As of March 31, 2023 and December 31, 2022, the Company had not experienced any significant losses on its accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the three months ended March 31, 2023, the Company sold to primarily three customers which made up approximately 78.77% of total Net revenue, and consisted of 40.14%, 25.08%, and 13.55% from an S&amp;P 500 Bank, Mastercard, and FIS, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">Additionally, during the three months ended March 31, 2022, the Company sold to primarily one customer, ICE, which made up approximately 79.42% of total Net revenue.</p>
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1418672
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
141000
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
120000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15121
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.30
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458633
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2821044
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
52000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
58000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1099824
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
215
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.40
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
387109
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y5M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
2408969
CY2023Q1 idai Maximum Number Of Warrants Issued To Purchase Common Stock In Future
MaximumNumberOfWarrantsIssuedToPurchaseCommonStockInFuture
1000000.00
CY2023Q1 idai Percentage Of Discount Of Future Issuance Of Preferred Stock
PercentageOfDiscountOfFutureIssuanceOfPreferredStock
0.20
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
50000
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6418
CY2023Q1 idai Schedule Of Assumptions Used To Calculate Fair Value Of Warrants Liabilities
ScheduleOfAssumptionsUsedToCalculateFairValueOfWarrantsLiabilities
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value of Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.96</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 92.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p>
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1181169
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1465083
CY2022Q3 idai Number Of Warrants Cancelled
NumberOfWarrantsCancelled
390000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.85
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
236470
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
225756
CY2023Q1 us-gaap Prepaid Rent
PrepaidRent
61412
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
55981
CY2023Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
82423
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
71742
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
66135
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
218239
CY2023Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
15804
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
8368
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
462244
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
580086
CY2023Q1 idai Capitalized Computer Software Useful Life
CapitalizedComputerSoftwareUsefulLife
P5Y
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3482118
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3314450
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2036455
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1895778
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1445663
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
176255
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
473202
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
94146
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
172538
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82109
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300664
CY2023Q1 us-gaap Depreciation
Depreciation
42000
CY2022Q1 us-gaap Depreciation
Depreciation
10000
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
177910
CY2023Q1 idai Short Term Financial Liabilities Related To Assets Held For Sale
ShortTermFinancialLiabilitiesRelatedToAssetsHeldForSale
177905
CY2023Q1 idai Liabilities Of Equipment Assets Held For Sale
LiabilitiesOfEquipmentAssetsHeldForSale
177905
CY2023Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
451000
CY2023Q2 idai Estimated Gain From Sale Of Properties
EstimatedGainFromSaleOfProperties
287000
CY2023Q1 idai Compensation Payable
CompensationPayable
224812
CY2022Q4 idai Compensation Payable
CompensationPayable
171851
CY2023Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
78176
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
58771
CY2023Q1 idai Accrued Employee Taxes
AccruedEmployeeTaxes
791534
CY2022Q4 idai Accrued Employee Taxes
AccruedEmployeeTaxes
591992
CY2023Q1 idai Accrued Mobile Expenses Current
AccruedMobileExpensesCurrent
10000
CY2022Q4 idai Accrued Mobile Expenses Current
AccruedMobileExpensesCurrent
177099
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86596
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
100111
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1191118
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
475071
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450641
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
236261
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
198955
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
238810
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251686
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
111006
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
88818
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
38166
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
820
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
238810
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2547450
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5044775
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4549686
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2022Q1 us-gaap Dilutive Securities
DilutiveSecurities
1799766
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
395002
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2647
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.01
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1230
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.25
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
756
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.94
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
387770
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.37
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y2M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
387770
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.37
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y2M15D
CY2023Q1 idai Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue1
0
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
37000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.00
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.72
CY2023Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
4000
CY2022Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
29000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59574
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
287786
CY2023Q1 idai Number Of Office Lease Terminated
NumberOfOfficeLeaseTerminated
2
CY2023Q1 idai Number Of Vehicle Lease Terminated
NumberOfVehicleLeaseTerminated
2
CY2023Q1 idai Lease Termination Fees
LeaseTerminationFees
11000
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
187
CY2023Q1 idai Financial Liability Obligation Termination Notice Term
FinancialLiabilityObligationTerminationNoticeTerm
P3M
CY2023Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Total
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountTotal
142215
CY2023Q1 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
0
CY2022Q1 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
29000
CY2023Q1 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2022Q4 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2020Q4 idai Loan Receivable Term
LoanReceivableTerm
P3Y
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
335000
CY2020Q4 idai Loans Receivable With Abated Interest Rate
LoansReceivableWithAbatedInterestRate
0.0025
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
281648
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.00
CY2020Q4 idai Loans Receivable Kind In Services Per Month
LoansReceivableKindInServicesPerMonth
9000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P36M
CY2023Q1 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
0
CY2022Q4 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
19000
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year One
PercentageOfCommissionReceivedOnNetSalesYearOne
0.20
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year Two
PercentageOfCommissionReceivedOnNetSalesYearTwo
0.10
CY2020Q4 idai Percentage Of Commission Received On Net Sales Year Three
PercentageOfCommissionReceivedOnNetSalesYearThree
0.05
CY2023Q1 idai Minimum Lease Commitments
MinimumLeaseCommitments
0
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M9D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023Q1 idai Number Of Leases Terminated
NumberOfLeasesTerminated
4
CY2023Q1 idai Number Of Leases Terminated
NumberOfLeasesTerminated
4
CY2023Q1 idai Lease Termination Fees
LeaseTerminationFees
10932
CY2023Q1 idai Right Of Use Assets Derecognized Upon Lease Termination
RightOfUseAssetsDerecognizedUponLeaseTermination
82982
CY2023Q1 idai Lease Liabilities Derecognized Upon Lease Termination
LeaseLiabilitiesDerecognizedUponLeaseTermination
77648
CY2023Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
187
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
166024
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
315765
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79269
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177795
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56739
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102407
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
136008
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
280202
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
62004
CY2023Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear
3742
CY2023Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountRemainderOfFiscalYear
65746
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
50610
CY2023Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year One
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne
2075
CY2023Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year One
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearOne
52685
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
22800
CY2023Q1 idai Lessee Operating Lease Liability Undiscounted Excess Amount Year Two
LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo
390
CY2023Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Two
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearTwo
23190
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
594
CY2023Q1 idai Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Three
LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearThree
594
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
136008
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6207
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
83034
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
21935
CY2023Q1 us-gaap Lease Cost
LeaseCost
104969
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
66546
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
178000
CY2023Q1 idai Financial Liability Obligation Termination Notice Term
FinancialLiabilityObligationTerminationNoticeTerm
P30D

Files In Submission

Name View Source Status
idai-20230331_cal.xml Edgar Link unprocessable
0001410578-23-001167-index-headers.html Edgar Link pending
0001410578-23-001167-index.html Edgar Link pending
0001410578-23-001167.txt Edgar Link pending
0001410578-23-001167-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idai-20230331.xsd Edgar Link pending
idai-20230331x10q.htm Edgar Link pending
idai-20230331xex31d1.htm Edgar Link pending
idai-20230331xex31d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
idai-20230331x10q_htm.xml Edgar Link completed
idai-20230331xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
idai-20230331_def.xml Edgar Link unprocessable
idai-20230331_lab.xml Edgar Link unprocessable
idai-20230331_pre.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending